People with Diabetes Tell FDA Not to Lock them Out of Monitoring and Treatment Devices
In response to an FDA request for public comment, more than a thousand individuals who use digital devices for diabetes monitoring and treatment have urged the agency not to lock them out in the name of cybersecurity.
🔒 Members Only · Cyber & AI BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.